Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 316,983
  • Shares Outstanding, K 54,278
  • Annual Sales, $ 1,044 M
  • Annual Income, $ -190,600 K
  • EBIT $ -33 M
  • EBITDA $ 83 M
  • 60-Month Beta 2.09
  • Price/Sales 0.29
  • Price/Cash Flow 2.94
  • Price/Book 0.56

Options Overview Details

View History
  • Implied Volatility 180.75% ( -1.05%)
  • Historical Volatility 116.71%
  • IV Percentile 83%
  • IV Rank 29.82%
  • IV High 509.14% on 04/04/25
  • IV Low 41.21% on 09/11/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 1,348
  • Volume Avg (30-Day) 820
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 15,160
  • Open Int (30-Day) 11,160

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.25
  • Number of Estimates 2
  • High Estimate 0.67
  • Low Estimate -0.18
  • Prior Year -2.32
  • Growth Rate Est. (year over year) +110.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.34 +35.48%
on 04/14/25
6.70 -12.24%
on 05/08/25
+1.49 (+33.94%)
since 04/11/25
3-Month
4.02 +46.27%
on 04/09/25
9.96 -40.95%
on 02/18/25
-3.62 (-38.11%)
since 02/13/25
52-Week
4.02 +46.27%
on 04/09/25
15.10 -61.06%
on 07/30/24
+0.52 (+9.70%)
since 05/13/24

Most Recent Stories

More News
Emergent Biosolutions: Q1 Earnings Snapshot

Emergent Biosolutions: Q1 Earnings Snapshot

EBS : 5.83 (-0.17%)
Emergent BioSolutions Reports First Quarter 2025 Financial Results

EBS : 5.83 (-0.17%)
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

EBS : 5.83 (-0.17%)
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

EBS : 5.83 (-0.17%)
JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

Share price of JAZZ Pharmaceuticals JAZZ hit $102.82 on Tuesday, close to its 52-week low of $99.06.This decline is attributable to the significant downturn in the broader biotech/drug sector due to the...

JAZZ : 101.83 (-1.69%)
EBS : 5.83 (-0.17%)
CMRX : 8.54 (-0.12%)
Emergent BioSolutions Announces Stock Repurchase Program

EBS : 5.83 (-0.17%)
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

EBS : 5.83 (-0.17%)
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

HIK.LN : 1,944.000 (-0.56%)
EBS : 5.83 (-0.17%)
HKMPY : 53.7700 (-0.77%)
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

EBS : 5.83 (-0.17%)
Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

EBS : 5.83 (-0.17%)

Business Summary

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside...

See More

Key Turning Points

3rd Resistance Point 6.36
2nd Resistance Point 6.19
1st Resistance Point 6.01
Last Price 5.83
1st Support Level 5.66
2nd Support Level 5.49
3rd Support Level 5.32

See More

52-Week High 15.10
Fibonacci 61.8% 10.87
Fibonacci 50% 9.56
Fibonacci 38.2% 8.25
Last Price 5.83
52-Week Low 4.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar